All times displayed in EST - for PST, please see the Full Event Guide

8:00 am Morning Networking

Synopsis

Grab a quick cup of tea or coffee from the comfort of your own home office and jump straight into your opportunity to connect with new contacts from active companies in the field and exchange digital business cards. Network and form lasting connections through this exclusive virtual speed networking!

8:40 am Opening Remarks from the Chair

Optimizing the Identification of Novel Targets: Evaluation of Antigen & Epitope Discovery

8:45 am Opening remarks from co-chair

8:50 am Overcoming Challenges of Target Discovery in Autoimmune Diseases

  • Mojca Skoberne Senior Vice President & Head of Immunology & Early Development, Repertoire Immune Medicines

9:20 am Monoclonal Antibodies Specific for Multiple Novel Targets to Suppress Type 1 Diabetes (t1d).

  • Li Zhang Assistant Professor Medicine-Endocrinology, Baylor College of Medicine

9:50 am Combination therapy with Tregitope and Cashew Improves & Accelerates Therapeutic Effects of Epicutaneous Immunotherapy in a Robust Mouse Model of Cashew Allergy

10:20 am Digital Speed Networking

Therapeutic immunization and using nanoparticles to delivery antigen-specific tolerogenic therapies

11:20 am Imotope™ IMCY-0098 for the Treatment of Type 1 Diabetes: Lessons From Phase 1 Study for Phase 2 IMPACT trial

11:50 am Can Antigen Specific Immune Therapy Control Tissue Resident Effector T cells in Human Type 1 Diabetes?

  • Matthias Von Herrath Vice President & Senior Medical Officer, Global Chief Medical Office, Novo Nordisk

12:20 pm Networking Lunch

1:00 pm TOL2 and TOL3: Antigen Specific Tolerogenic Therapies for the Treatment of Myasthenia Gravis and ANCA vasculitis

1:30 pm Delivery of Autoantigenic peptides/proteins to APCs Using Nanoparticle Vehicles; Challenges In the Pursuit of Immune Tolerance in Progressive Autoimmune Diseases

  • Ranjeny Thomas Professor of Rheumatology, University of Queensland, Translational Research Institute

2:00 pm Networking Break

2:30 pm Treg-Enhancing Approaches to Drive Tolerance Induction in the Clinic

3:00 pm Magnifying Antigen-Specific Tolerance

  • Randolph Noelle Professor, Dartmouth Medical School; Co- Founder & Vice Chair, ImmuNext

Next Steps for the Immune Tolerance Research Field

3:30 pm Panel: Developing Precision Immune Tolerance Therapeutics

4:00 pm Chair’s Closing Remarks

4:10 pm End of Conference